Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rintaro Hashizume

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Acta Neuropathologica Communications|October 24, 2022
Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine gliomaGuisheng Zhao, Patrick Newbury, Yukitomo Ishi, et al.
Acta Neuropathologica Communications|July 27, 2019
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacyYu Kanemaru, Manabu Natsumeda, Masayasu Okada, et al.
Nature Communications|February 9, 2023
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cellsQingnan Zhao, Jiemiao Hu, Lingyuan Kong, et al.
The Journal of Clinical Investigation|May 30, 2023
Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutationsZibo Zhao, Kaixiang Cao, Jun Watanabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2024
Editor's Note: BRAF Status in Personalizing Treatment Approaches for Pediatric GliomasAleksandra Olow, Sabine Mueller, Xiaodong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2016
BRAF Status in Personalizing Treatment Approaches for Pediatric GliomasAleksandra Olow, Sabine Mueller, Xiaodong Yang, et al.
Journal of Neuro-Oncology|September 20, 2015
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Journal of Neuro-Oncology|January 20, 2016
Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Neuro-Oncology|January 20, 2021
Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine gliomaHiroaki Katagi, Nozomu Takata, Yuki Aoi, et al.
Cell|October 20, 2018
Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer TherapyKaiwei Liang, Edwin R Smith, Yuki Aoi, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Acta Neuropathologica Communications|October 24, 2022
Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine gliomaGuisheng Zhao, Patrick Newbury, Yukitomo Ishi, et al.
Acta Neuropathologica Communications|July 27, 2019
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacyYu Kanemaru, Manabu Natsumeda, Masayasu Okada, et al.
Nature Communications|February 9, 2023
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cellsQingnan Zhao, Jiemiao Hu, Lingyuan Kong, et al.
The Journal of Clinical Investigation|May 30, 2023
Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutationsZibo Zhao, Kaixiang Cao, Jun Watanabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2024
Editor's Note: BRAF Status in Personalizing Treatment Approaches for Pediatric GliomasAleksandra Olow, Sabine Mueller, Xiaodong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2016
BRAF Status in Personalizing Treatment Approaches for Pediatric GliomasAleksandra Olow, Sabine Mueller, Xiaodong Yang, et al.
Journal of Neuro-Oncology|September 20, 2015
Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Journal of Neuro-Oncology|January 20, 2016
Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaTina Dasgupta, Aleksandra K Olow, Xiaodong Yang, et al.
Neuro-Oncology|January 20, 2021
Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine gliomaHiroaki Katagi, Nozomu Takata, Yuki Aoi, et al.
Cell|October 20, 2018
Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer TherapyKaiwei Liang, Edwin R Smith, Yuki Aoi, et al.
Pageof 9